Literature DB >> 23474875

Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching.

Michael R Tallack1, Andrew C Perkins.   

Abstract

PURPOSE OF REVIEW: Krüppel-like factor 1 (KLF1) regulates most aspects of erythropoiesis. Many years ago, transgenic mouse studies implicated KLF1 in the control of the human γ-globin to β-globin switch. In this review, we will integrate these initial studies with recent developments in human genetics to discuss our present understanding of how KLF1 and its target genes direct the switch. RECENT
FINDINGS: Recent studies have shown that human mutations in KLF1 are common and mostly asymptomatic, but lead to significant increases in levels of fetal hemoglobin (HbF) (α2γ2) and adult HbA2 (α2δ2). Genome-wide association studies (GWAS) have demonstrated that three primary loci are associated with increased HbF levels in the population: the β-globin locus itself, the BCL11A locus, and a site between MYB and HBS1L. We discuss evidence that KLF1 directly regulates BCL11A, MYB and other genes, which are involved directly or indirectly in γ-globin silencing, thus providing a link between GWAS and KLF1 in hemoglobin switching.
SUMMARY: KLF1 regulates the γ-globin to β-globin genetic switch by many mechanisms. Firstly, it facilitates formation of an active chromatin hub (ACH) at the β-globin gene cluster. Specifically, KLF1 conscripts the adult-stage β-globin gene to replace the γ-globin gene within the ACH in a stage-specific manner. Secondly, KLF1 acts as a direct activator of genes that encode repressors of γ-globin gene expression. Finally, KLF1 is a regulator of many components of the cell cycle machinery. We suggest that dysregulation of these genes leads to cell cycle perturbation and 'erythropoietic stress' leading to indirect upregulation of HbF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474875     DOI: 10.1097/MOH.0b013e32835f59ba

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  31 in total

1.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

2.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

3.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

4.  A step forward back to (induced) fetal.

Authors:  Nancy S Green
Journal:  Blood       Date:  2014-08-14       Impact factor: 22.113

5.  Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche.

Authors:  Li Xue; Mariann Galdass; Merlin Nithya Gnanapragasam; Deepa Manwani; James J Bieker
Journal:  Development       Date:  2014-06       Impact factor: 6.868

6.  Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.

Authors:  Priya Hariharan; Madhavi Sawant; Manju Gorivale; Ruma Manchanda; Roshan Colah; K Ghosh; Anita Nadkarni
Journal:  Mol Biol Rep       Date:  2017-09-06       Impact factor: 2.316

7.  The genetics of hemoglobin A2 regulation in sickle cell anemia.

Authors:  Paula J Griffin; Paola Sebastiani; Heather Edward; Clinton T Baldwin; Mark T Gladwin; Victor R Gordeuk; David H K Chui; Martin H Steinberg
Journal:  Am J Hematol       Date:  2014-08-04       Impact factor: 10.047

8.  KLF1/EKLF expression in acute leukemia is correlated with chromosomal abnormalities.

Authors:  Adnan Mansoor; Mohammad Omer Mansoor; Jay L Patel; Shuchun Zhao; Yasodha Natkunam; James J Bieker
Journal:  Blood Cells Mol Dis       Date:  2020-04-13       Impact factor: 3.039

Review 9.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

10.  KLF1: when less is more.

Authors:  Deepa Manwani; James J Bieker
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.